You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SGI-110

Showing 1 - 25 of 533
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

Active, not recruiting
  • High Risk Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary

Suspended
  • Locally Advanced Unresectable Primary Central Chondrosarcoma
  • +2 more
  • Phoenix, Arizona
  • +38 more
Feb 2, 2023

Acute Myeloid Leukemia Trial in Kyoto, Region (SGI-110)

Completed
Has Results
  • Acute Myeloid Leukemia
  • SGI-110
  • Kyoto, Japan
  • +2 more
Feb 12, 2021

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +5 more
  • Tucson, Arizona
  • +16 more
Oct 19, 2022

Metastatic Colorectal Cancer Trial in Baltimore (CY, GVAX, SGI-110)

Completed
  • Metastatic Colorectal Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 26, 2021

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • SGI-110
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

Colorectal Adenocarcinoma, CpG Island Methylator Phenotype, Metastatic Microsatellite Stable Colorectal Carcinoma Trial in Los

Withdrawn
  • Colorectal Adenocarcinoma
  • +7 more
  • Los Angeles, California
  • +1 more
Apr 1, 2021

Previously Treated Metastatic Colorectal Cancer Trial in Netherlands, United States (SGI-110 Dose Escalation, Regorafenib,

Completed
Has Results
  • Previously Treated Metastatic Colorectal Cancer
  • SGI-110 Dose Escalation
  • +4 more
  • Los Angeles, California
  • +3 more
Sep 14, 2020

Germ Cell Tumor, Testis Cancer, Testicular Cancer Trial in Indianapolis (Guadecitabine (SGI-110))

Completed
  • Germ Cell Tumor
  • +2 more
  • Guadecitabine (SGI-110)
  • Indianapolis, Indiana
  • +1 more
Sep 22, 2020

Small Cell Lung Cancer, Extensive-stage Small Cell Lung Cancer Trial in United States (Guadecitabine, Carboplatin)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extensive-stage Small Cell Lung Cancer
  • Indianapolis, Indiana
  • +3 more
Feb 14, 2022

Ovarian Cancer Trial in Canada, United Kingdom, United States (SGI-110, Treatment of Choice (topotecan, pegylated liposomal

Completed
Has Results
  • Ovarian Cancer
  • SGI-110
  • +2 more
  • Los Angeles, California
  • +23 more
Apr 30, 2021

Advanced Kidney Cancer, Kidney Cancer, Clear Cell Renal Cell Carcinoma Trial in United States (Guadecitabine, Durvalumab)

Active, not recruiting
  • Advanced Kidney Cancer
  • +2 more
  • Chicago, Illinois
  • +4 more
Feb 16, 2022

Acute Myeloid Leukemia, Myeloid Dysplastic Syndrome Trial in Worldwide (Guadecitabine)

Terminated
  • Acute Myeloid Leukemia
  • Myeloid Dysplastic Syndrome
  • Buffalo, New York
  • +20 more
Jan 21, 2022

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
Sep 1, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • SGI-110 (guadecitabine)
  • Treatment Choice
  • Scottsdale, Arizona
  • +134 more
Dec 21, 2020

Hepatocellular Carcinoma Trial in Canada, United Kingdom, United States (SGI-110)

Completed
Has Results
  • Hepatocellular Carcinoma
  • SGI-110
  • Duarte, California
  • +23 more
Jan 13, 2020

Acute Myeloid Leukemia Trial in Worldwide (guadecitabine, Treatment Choice (TC))

Completed
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +94 more
Sep 5, 2021

Melanoma, Non Small Cell Lung Cancer Trial in Siena (Ipilimumab plus nivolumab plus guadecitabine, Ipilimumab plus nivolumab)

Not yet recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Ipilimumab plus nivolumab plus guadecitabine
  • Ipilimumab plus nivolumab
  • Siena, Italy
    Center for Immuno-Oncology, University Hospital of Siena
Jan 29, 2020

Extensive-stage Small Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab, SGI-110)

Completed
  • Extensive-stage Small Cell Lung Cancer
  • New York, New York
    Columbia University Medical Center
Dec 7, 2018

MDS, Acute Myeloid Leukemia Trial in France (Guadecitabine)

Unknown status
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Angers, France
  • +11 more
Nov 13, 2018

MDS Trial in France (SGI-110 administration)

Completed
  • MDS
  • SGI-110 administration
  • Angers, France
  • +26 more
Dec 5, 2018

Bunion Trial in Bellaire (Ropivacaine)

Recruiting
  • Bunion
  • Bellaire, Texas
    First Surgical Hospital 4801 Bissonnet Street
Mar 6, 2023

Refractory Chronic Cough Trial in Phoenix, Leesburg, Winter Park (3 mg NOC-100 (via nebulizer), 1 mg NOC-110 (via DPI) [1x 1 mg

Completed
  • Refractory Chronic Cough
  • 3 mg NOC-100 (via nebulizer)
  • +5 more
  • Phoenix, Arizona
  • +2 more
Nov 16, 2022